StockGlow

Daiichi Sankyo Company, Limited (DSKYF)

Develops cancer drugs and treatments for heart disease, diabetes, and other serious conditions

$17.50+0.10%Healthcare
Compare DSKYF with
StockGlow Score
33
Leaning Bearish
BearishBullish
1 year ago-28.1%

The outlook

DSKYF is trading near the lower end of its 52-week range and sits mixed relative to its moving averages, suggesting choppy momentum. The stock carries a trailing P/E of 20.3, and analyst sentiment leans bearish overall. The current price sits significantly below recent highs, indicating the stock remains in a weaker part of its yearly trading band.

What’s behind the score

Price trendMixed vs its moving averages
52-week range24% of the way from its 52-week low to high
Market cap
$31.84B
52-wk high
$29.15
52-wk low
$13.85
50-day avg
$16.37
200-day avg
$19.57
Trailing P/E
20.3

Similar stocks

DSNKYDaiichi Sankyo Company, Limited$17.87+2.70%CHGCYChugai Pharmaceutical Co., Ltd.$21.41+2.44%ALPMFAstellas Pharma Inc.$13.15+2.33%TKPHFTakeda Pharmaceutical Company Limited$32.60+4.52%MKGAFMerck KGaA$167.51+4.75%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy